Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

April 4, 2022

Study Completion Date

April 4, 2022

Conditions
Acute Coronary Syndrome
Interventions
OTHER

Sprints

"Two sprints of 8 seconds on a cycle ergometer will be performed for determine Force/Velocity Profile (FVP).~Realized at inclusion and 2 months after."

OTHER

Vertical jumps

"Two vertical jumps will be performed. Height of theses vertical jumps will be measured by application My jump 2 to determine muscle power.~Realized at inclusion and 2 months after."

OTHER

Questionary Short Form-12 (SF-12)

"Questionary Short Form-12 (SF-12) will be performed to evaluate quality of life. It is composed of 12 questions.~Realized at inclusion and 2 months after."

DEVICE

activity actigraph

"Activity actigraph will be wearing by patient during 7 consecutive days. It measures the level of physical activity and the sedentary lifestyle of patients.~Realized at inclusion and 2 months after."

OTHER

Program composed of two 2 training strategies

"Program composed of two 2 training strategies according to the initial Force/Velocity Profile (FVP) will be realized at the inclusion.~There are :~* Strategy experimental-speed: speed training strategy for subjects with a force-speed profile (PFV) in favour of force~* Strategy experimental-force: force training strategy for subjects with a force-speed profile (PFV) in favour of speed."

OTHER

Program of usual practice

Program composed of training in force and speed independently of the initial Force/Velocity Profile (FVP).

Trial Locations (1)

Unknown

Chu Saint-Etienne, Saint-Etienne

All Listed Sponsors
collaborator

Jean Monnet University

OTHER

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients | Biotech Hunter | Biotech Hunter